Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
Species
- (2)
- (2)
- (6)
- (6)
- (6)
- (6)
- (2)
- (12)
- (1,874)
- (108)
- (1)
- (1)
- (4)
- (51)
- (5)
- (8)
- (2)
- (15)
- (1)
- (3)
- (450)
- (8)
- (6)
- (1)
- (1)
- (28,501)
- (1)
- (8)
- (3)
- (15)
- (1)
- (3)
- (13)
- (1)
- (7)
- (1)
- (3)
- (2)
- (3)
- (4)
- (3)
- (2)
- (7)
- (3)
- (3)
- (4)
- (4)
- (2)
- (2)
- (2)
- (1)
- (4)
- (1)
- (32,573)
- (202)
- (37)
- (19)
- (17)
- (8)
- (4)
- (1)
- (3)
- (2)
- (6)
- (211)
- (2)
- (2)
- (1,331)
- (18)
- (2)
- (1)
- (2)
- (14)
- (1)
- (52)
- (2)
- (2)
- (2)
- (1)
- (42)
- (16)
- (46)
- (31)
- (2)
- (58)
- (4)
- (190)
- (1)
- (172)
- (13)
- (12)
- (3)
- (6)
- (4)
- (120)
- (4)
- (3)
- (3)
- (2)
- (2)
- (2)
- (14)
- (30,025)
- (4)
- (4,512)
- (2)
- (1)
- (4)
Regulatory Status
- (85)
- (97,395)
For Use With (Application)
- (1)
- (2)
- (1)
- (3,448)
- (1)
- (28,534)
- (30)
- (65)
- (548)
- (9,435)
- (24)
- (1)
- (8)
- (2)
- (8)
- (3)
- (2)
- (2)
- (1)
- (8)
- (231)
- (2)
- (2)
- (2)
- (1)
- (2)
- (2)
- (3)
- (1)
- (1)
- (5)
- (1)
- (1)
- (248)
- (3)
- (27,192)
- (1)
- (16)
- (1)
- (1)
- (32)
- (4)
- (1)
- (49,471)
- (1,401)
- (2)
- (4)
- (3)
- (37)
- (791)
- (4)
- (3)
- (200)
- (1)
- (1)
- (133)
- (1)
- (416)
- (2,826)
- (3)
- (65)
- (7)
- (566)
- (4)
- (1)
- (19,645)
- (23)
- (2)
- (32)
- (19)
- (3)
- (182)
- (21)
- (1)
- (3)
- (121)
- (150)
- (98)
- (2)
- (2)
- (15)
- (3)
- (1)
- (1,610)
- (2)
- (4)
- (1)
- (37)
- (690)
- (2)
- (1)
- (2)
- (2)
- (9)
- (11)
- (2)
- (21,975)
- (4,211)
- (3)
- (4)
- (8)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (1)
- (47,864)
- (198)
- (15)
- (2)
- (1)
- (197)
- (62)
- (4)
- (6)
- (22)
- (1)
- (3)
- (1)
- (6)
- (1)
- (197)
- (1)
- (10,963)
- (4)
- (53)
- (1)
- (5)
- (14)
- (2)
- (4)
- (12)
- (5)
- (8)
- (1)
- (1)
- (49,847)
- (1,915)
Recombinant
- (17)
- (70,760)
- (18)
Form
- (3)
- (19)
- (51,752)
- (8,490)
- (3,530)
- (136)
- (17)
- (3,406)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Search Within Results
Keyword Search:
Clear All
1
–
15
of
83,089
results
2
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human EGF |
| Purification Method | Purified |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Stem Cell Research, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | EGF |
| Storage Requirements | 4°C |
| Protein Subtype | EGF (Epidermal Growth Factor) |
| Accession Number | P01133 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 1950 |
| Product Line | Gibco |
3
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | M-CSF |
| Molecular Weight (g/mol) | 36.4 kDa |
| Gene Symbol | Csf1 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MKEVSEHCSH MIGNGHLKVL QQLIDSQMET SCQIAFEFVD QEQLDDPVCY LKKAFFLVQD IIDETMRFKD NTPNANATER LQELSNNLNS CFTKDYEEQN KACVRTFHET PLQLLEKIKN FFNETKNLLE KDWNIFTKNC NNSFAKCSSR DVVTKP |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control,ELISA Standard,Western Blot Control |
| Source | E. coli |
| Name | Mouse M-CSF |
| Accession Number | P07141 |
| Gene Alias | C87615; colony stimulating factor 1; colony stimulating factor 1 (macrophage); colony-stimulating factor-1 splice variant; CSF1; CSF-1; Csfm; H-MCSF; lanimostim; macrophage colony stimulating factor 1; macrophage colony stimulating factor alpha; macrophage colony stimulating factor beta; macrophage colony-stimulating factor; macrophage colony-stimulating factor 1; macrophage colony-stimulating factor beta; macrophage-colony stimulating factor alpha; MCSF; MCSF alpha; MCSFBETA; MGC31930; M-MCSF; op; osteopetrosis; Processed macrophage colony-stimulating factor 1 |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of the proliferation of M-NFS-60 cells is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 12977 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
4
Promotions Available
Gibco™ Human TPO (Thrombopoietin) Recombinant Protein, PeproTech®
![]()
Gibco™ Human TPO (Thrombopoietin) Recombinant Protein, PeproTech®
Recombinant Protein
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | Thrombopoietin |
| Molecular Weight (g/mol) | 18.6 kDa |
| Gene Symbol | THPO |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | SPAPPACDLR VLSKLLRDSH VLHSRLSQCP EVHPLPTPVL LPAVDFSLGE WKTQMEETKA QDILGAVTLL LEGVMAARGQ LGPTCLSSLL GQLSGQVRLL LGALQSLLGT QLPPQGRTTA HKDPNAIFLS FQHLLRGKVR FLMLVGGSTL CVRRAPPTTA VPSRTSLVLT LNEL |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human TPO (Thrombopoietin) |
| Accession Number | P40225 |
| Gene Alias | C-mpl ligand; Megakaryocyte colony-stimulating factor; megakaryocyte growth and development factor; megakaryocyte stimulating factor; Mgdf; MKCSF; ML; MPL ligand; Mpllg; MSA; Myeloproliferative leukemia virus oncogene ligand; prepro-thrombopoietin; TDH2A; THCYT1; THPO; Thrombopoietin; thyroid microsomal antigen; thyroid peroxidase; thyroperoxidase; Tpo; TPX |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of the proliferation of human MO7e cells was found to be ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 7066 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
5
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IGF-I LR3 |
| Molecular Weight (g/mol) | 9.1 kDa |
| Gene Symbol | IGF1 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MFPAMPLSSL FVNGPRTLCG AELVDALQFV CGDRGFYFNK PTGYGSSSRR APQTGIVDEC CFRSCDLRRL EMYCAPLKPA KSA |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control |
| Source | E. coli |
| Name | Human IGF-I LR3 |
| Accession Number | P05019 |
| Gene Alias | IGF-I |
| Biological Activity | The ED50 was determined by a cell proliferation assay using FDC-P1 cells is ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg |
| Gene ID (Entrez) | 3479 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
6
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | FGF2 |
| Molecular Weight (g/mol) | 17 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 ≤ 1.0 ng/mL; determined by the dose-dependent proliferation of BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human FGF-basic (FGF-2/bFGF) (aa 10-155) |
| Purification Method | Purified |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Protein Form | Recombinant, Ligand, Truncated |
| Biological Activity | ED50 ≤ 1.0 ng/mL; determined by the dose-dependent proliferation of BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Research Category | Neurobiology, Oncology, Stem Cell Research, Microbiology, Differentiation, Angiogenesis |
| Species | Human |
| Recombinant | Recombinant |
| Content And Storage | 4°C |
| Gene Symbol | FGF2 |
| Sequence | Human FGF-basic, amino acids 10-155 |
| Storage Requirements | 4°C |
| Protein Subtype | FGFs (Fibroblast Growth Factors) |
| Accession Number | P09038 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 2247 |
| Product Line | Gibco |
7
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >98% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | GDNF |
| Molecular Weight (g/mol) | 30.1 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 ≤ 10 n/mL; determined by the dose-dependent neurite outgrowth of PC-12 cells in the presence of soluble GFR-alpha. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human GDNF |
| Purification Method | Purified |
| Gene Alias | AI385739; Astrocyte-derived trophic factor; ATF; ATF1; ATF2; Gdnf; glial cell derived neurotrophic factor; glial cell line derived neurotrophic factor; Glial cell line derived neutrophic factor; glial cell line-derived neurotrophic factor; gndf; HFB1-GDNF; hGDNF; H-GDNF; HSCR3; mGDNF; neurotrophic factor |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 ≤ 10 n/mL; determined by the dose-dependent neurite outgrowth of PC-12 cells in the presence of soluble GFR-alpha. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Neurobiology, Stem Cell Research, Differentiation |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Approved for shipment on Wet or Dry Ice |
| Content And Storage | 4°C |
| Gene Symbol | GDNF |
| Sequence | SPDKQMAVLP RRERNRQAAA ANPENSRGKG RRGQRGKNRG CVLTAIHLNV TDLGLGYETK EELIFRYCSG SCDAAETTYD KILKNLSRNR RLVSDKVGQA CCRPIAFDDD LSFLDDNLVY HILRKHSAKR CGCI |
| Storage Requirements | 4°C |
| Protein Subtype | Neurotrophic Factors |
| Accession Number | P39905 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 2668 |
| Product Line | Gibco |
8
Corning™ Laminin, Mouse
Promotes cell adhesion, migration, growth, and differentiation, including neurite outgrowth
9
| Protein Family | Cytokines & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | TNF alpha |
| Molecular Weight (g/mol) | 17.5 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 0.05 ng/mL; determined by the dose-dependent cytotoxcity on L929 cells in the presence of actinomycin D. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human TNF-alpha |
| Purification Method | Purified |
| Gene Alias | APC1 protein; Cachectin; C-domain 1; C-domain 2; cTNF; DADB-70P7.1; DIF; ICD1; ICD2; Intracellular domain 1; Intracellular domain 2; N-terminal fragment; NTF; RATTNF; Tnf; TNF alpha; TNF superfamily; TNF α; TNF, macrophage-derived; TNF, monocyte-derived; TNFA; TNF-a; TNFalpha; TNF-alpha; Tnfsf1a; TNFSF2; TNFα; TNLG1F; Tumor necrosis factor; tumor necrosis factor (TNF superfamily, member 2); tumor necrosis factor alpha; tumor necrosis factor alpha (cachetin); tumor necrosis factor alpha precursor; tumor necrosis factor ligand 1F; tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor, membrane form; Tumor necrosis factor, soluble form; tumor necrosis factor-alpha; tumor necrosis factor-alpha precursor; tumor-necrosis factor; tumour necrosis factor |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 0.05 ng/mL; determined by the dose-dependent cytotoxcity on L929 cells in the presence of actinomycin D. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Immunology, Signal Transduction, Stem Cell Research, Inflammation, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | Tnf |
| Sequence | VRSSSRTPSD KPVAHVVANP QAEGQLQWLN RRANALLANG VELRDNQLVV PSEGLYLIYS QVLFKGQGCP STHVLLTHTI SRIAVSYQTK VNLLSAIKSP CQRETPEGAE AKPWYEPIYL GGVFQLEKGD RLSAEINRPD YLDFAESGQV YFGIIAL |
| Storage Requirements | 4°C |
| Protein Subtype | TNF (Tumor Necrosis Factor) |
| Accession Number | P01375 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 7124 |
| Product Line | Gibco |
11
Corning™ Ultrapure Laminin, Mouse
SureTRACE
Supports traceability with guaranteed access to certificates and proactive change notifications.
Learn More
SureTRACE
Supports traceability with guaranteed access to certificates and proactive change notifications.
Learn More
Supports traceability with guaranteed access to certificates and proactive change notifications.
Learn More
Promotes cell adhesion, migration, growth, and differentiation, including neurite outgrowth
12
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | Granzyme B |
| Molecular Weight (g/mol) | 26.6 kDa |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | IIGGHEAKPH SRPYMAYLMI WDQKSLKRCG GFLIRDDFVL TAAHCWGSSI NVTLGAHNIK EQEPTQQFIP VKRPIPHPAY NPKNFSNDIM LLQLERKAKR TRAVQPLRLP SNKAQVKPGQ TCSVAGWGQT APLGKHSHTL QEVKMTVQED RKCESDLRHY YDSTIELCVG DPEIKKTSFK GDSGGPLVCN KVAQGIVSYG RNNGMPPRAC TKVSSFVHWI KKTMKRYHHH HHHHH |
| Expression System | CHO cells |
| For Use With (Application) | Control,Enzyme Activity,Bioactivity |
| Name | Human Granzyme B |
| Accession Number | P10144 |
| Gene Alias | AI553453; C11; Cathepsin G-like 1; CCP1; CCP-1/C11; CCPI; CGL1; CGL-1; CSPB; CSP-B; Ctla1; Ctla-1; CTSGL1; cytotoxic cell protease 1; cytotoxic serine protease B; Cytotoxic T lymphocyte associated serine esterase 1; cytotoxic T-lymphocyte proteinase 2; cytotoxic T-lymphocyte-associated serine esterase 1; fragmentin; fragmentin 2; fragmentin-2; GLP I; GLP III; GLP-1; granzyme 2; granzyme B; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1); granzyme B(G,H); Granzyme-2; GranzymeB; granzyme-like protein 1; granzyme-like protein I; GRB; GZB; Gzmb; HLP; human lymphocyte protein; Human lymphocyte protein (Hlp); Lymphocyte protease; Natural killer cell protease 1; OTTHUMP00000028189; RNKP-1; SECT; T-cell serine protease 1-3E |
| Format | Lyophilized |
| Biological Activity | Determined by its ability to cleave chromogentic Granzyme B substrate IEPD-pNA |
| Gene ID (Entrez) | 3002 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
13
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | TGF beta-1 |
| Molecular Weight (g/mol) | 25 kDa |
| Gene Symbol | Tgfb1 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | ALDTNYCFSS TEKNCCVRQL YIDFRKDLGW KWIHEPKGYH ANFCLGPCPY IWSLDTQYSK VLALYNQHNP GASAAPCCVP QALEPLPIVY YVGRKPKVEQ LSNMIVRSCK CS |
| Expression System | HEK293 cells |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Source | HEK293 cells |
| Name | Human TGF-beta 1 |
| Accession Number | P01137 |
| Gene Alias | CED; cytokine; DPD1; LAP; Latency-associated peptide; prepro-transforming growth factor beta-1; regulatory protein; TGF b; TGF b 1; TGF beta; tgf beta 1; tgf beta1; TGF beta-1; TGF beta-1 protein; TGF β; TGF β 1; TGF β1; Tgfb; TGFB1; TGF-B1; Tgfb-1; TGFbeta; TGF-beta 1; TGF-beta 1 protein; TGFbeta1; TGF-beta1; TGF-beta-1; TGFβ1; Transforming growth factor; transforming growth factor b1; transforming growth factor beta; transforming growth factor beta 1; transforming growth factor beta-1; Transforming growth factor beta-1 proprotein; transforming growth factor beta-1 proprotein; transforming growth factor beta-1; transforming growth factor β1; transforming growth factor, beta 1; transforming growth factor, beta 1 (Camurati-Engelmann disease); transforming growth factor, beta-1; transforming growth factor-beta 1; transforming growth factor-beta I; transforming growth factor-beta-1; transforming growth factor-beta-1 precursor; unnamed protein product |
| Biological Activity | The ED50 was determined by TGF-beta1's ability to inhibit the mouse IL-4-dependent proliferation of mouse HT-2 cells is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
| Gene ID (Entrez) | 7040 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
14
Promotions Available
Gibco™ Human EGF, Animal-Free Recombinant Protein, PeproTech®
![]()
Gibco™ Human EGF, Animal-Free Recombinant Protein, PeproTech®
Recombinant Protein
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Gene Symbol | EGF |
| Endotoxin Concentration | <0.1 EU/μg |
| Sequence | NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human EGF, Animal-Free |
| Accession Number | P01133 |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Biological Activity | The ED50 was determined by a cell proliferation assay using balb/c 3T3 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 1950 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
15
MP BIOMEDICALS SARS-CoV-2 Nucleocapsid Protein His Tagged
Recombinant His-tagged SARS-CoV-2 Nucleocapsid protein, with polyhistidine tag at the N- and C-terminus. Expressed in E. coli.
| Conjugate | His-Tag |
|---|---|
| Form | Lyophilized |
| Product Type | SARS-CoV-2 Nucleocapsid Protein |
| For Use With (Application) | Drug Discovery and Development |
| Species | Human |
| Recombinant | Recombinant |